loader
Please Wait
Applying Filters...
menu
    • menu

    Finished Formulations with Kaolin Excipient

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Kaolin Excipient

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1FELODIPINE

    02 1FLECTOR

    03 1LEVETIRACETAM

    04 2LIDOCAINE

    05 1LIDODERM

    06 1RIFATER

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers

    01

    SANOFI AVENTIS US
    France
    arrow
    CPhI Worldwide, Milan
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    ISONIAZID; PYRAZINAMIDE; RIFAMPIN

    Drug : RIFATER

    Dosage Form : TABLET; ORAL

    Application Number : 50705

    Country : US

    Patented : No

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACTAVIS LABS UT INC

    Lidocaine

    Discovery on Target
    Not Confirmed
    arrow

    03

    DEXCEL

    Levetiracetam

    Discovery on Target
    Not Confirmed
    arrow
    DEXCEL
    Israel
    arrow
    Discovery on Target
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    LEVETIRACETAM

    Drug : LEVETIRACETAM

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Application Number : 202167

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    GLENMARK PHARMS LTD

    Felodipine

    Discovery on Target
    Not Confirmed
    arrow

    05

    IBSA

    Diclofenac Epolamine

    Discovery on Target
    Not Confirmed
    arrow

    06

    IBSA

    Lidocaine

    Discovery on Target
    Not Confirmed
    arrow

    07

    TEIKOKU PHARMA USA

    Lidocaine

    Discovery on Target
    Not Confirmed
    arrow